logo-loader
CSE:PMED OTCQB:PMEDF

Predictmedix AI Inc.

Receive alerts
Market:
CSE
Price
0.05 CAD
Day Change
-
Market Cap:
$6.65 m
52 weeks high
0.16
52 weeks low
0.04

In brief

Predictmedix AI Inc is an artificial intelligence (AI) company, which is developing disruptive tools for impairment testing and health care aimed at use across various workplaces and by law enforcement agents.

The technology uses facial and voice recognition to identify both cannabis and alcohol impairment by utilizing multiple features along with numerous data points.

Amid the current coronavirus (COVID-19) pandemic, the team realized the same multi-spectral imaging and AI methods could be deployed to identify virus symptoms and has developed its Safe Entry Stations. People walk through modules (like a tunnel) linked to cloud software and, within fractions of a second, a green or red light appears, identifying those who are exhibiting symptoms.

The firm's technology is focused broadly on four areas - impairment, infectious disease, mental health and remote patient monitoring/telehealth. Dr Rahul Kushwah, president and COO of Predictmedix says the market opportunity across this spectrum is enormous - up to an eye-watering US$300 billion.

The company was co-founded by Kushwah, a former Professor at the University of Ottawa's medical school and a scientist with the government of Canada (National Research Council) turned entrepreneur, and capital markets specialist Sheldon Kales who is a serial entrepreneur and has led the transition of several companies from private space to public trading.

Snapshot

  • Predictmedix AI targets US government with new partnership
  • Predictmedix unveils accuracy rates for Monitoring of Physiological Parameters with Safe Entry